Top

Published in:

01-01-2008 | Case report

Rapid oral desensitisation procedure in clopidogrel hypersensitivity

Authors: B. Oppedijk, D. A. M. Odekerken, J. J. van der Wildt, C. F. Melissant

Published in: Netherlands Heart Journal | Issue 1/2008

Abstract

We describe a patient who developed generalised pruritis with oedema and rash two weeks after she had started taking clopidogrel following coronary stent implantation. In the absence of other likely causative agents, clopidogrel hypersensitivity was probable. She was treated with a rapid oral desensitisation procedure, after which a daily dose of 75 mg clopidogrel was well tolerated. No major adverse events occurred during a follow-up period of eight months. Oral desensitisation in clopidogrel hypersensitivity seems to be a safe method to reduce the risk of coronary stent thrombosis. (Neth Heart J 2008;16:21-3).

Patrono C, Coller B, FitzGerald GA, Hirsh J, Roth G. Plateletactive drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(suppl):234S-264S.

McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004;364:1519-21.

Ong AT, Hoye A, Aoki J, van Mieghem CA, Rodriguez Granillo GA, Sonnenschein K, et al. Thirty day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol 2005;45:947-53.

Gowda RM, Misra D, Khan IA. Hypersensitivity skin rash: an adverse drug reaction to clopidogrel loading dose. Int J Cardiol 2004;95:333.

Comert A, Akgun S, Civelek A, Kavala M, Sarigül S, Yildirim T, et al. Clopidogrel-induced hypersensitivity syndrome associated with febrile pancytopenia. Int J Dermatol 2005;44:882-4.

Doogue MP, Begg EJ, Bridgman P. Clopidogrel Hypersensitivity Syndrome With Rash, Fever, and Neutropenia. Mayo Clin Proc 2005;80:1386-70.

Ten Berg JM, van Werkum JW, Heestermans AACM, Jaarsma W, Hautvast RMA, den Heijer P, et al. Antiplatelet therapy in patients undergoing coronary stenting – the risk of late stent thrombosis. Neth Heart J 2006;14:297-300.

Van Werkum JW, Heestermans AACM, Jaarsma W, Hautvas RWM, de Boer MJ, ten Berg JM. Trombose van een coronaire stent na het staken van behandeling met clopidogrel. Ned Tijdschr Geneeskd 2006;150:863-8.

Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.

10.

World Health Organization: Adverse events following immunization (AEFI): causality assessment. http://www.who.int/vaccinesdocuments/DocsPDF05/815.pdf.

11.

Szto GY, Linnemeier TJ, Ball MW. Fatal neutropenia and thrombocytopenia associated with ticlopidine after stenting. Am J Cardiol 1999;83:138-9.

12.

Silberman S, Neukirch-Stoop C, Steg PG. Rapid desensitisation procedure for patients with aspirin hypersensitivity undergoing coronary stenting. Am J Cardiol 2005;95:509-10.

13.

Camara MG, Almeda FQ. Clopidogrel (Plavix) desensitisation: a case series. Cathet Cardiovasc Intervent 2005;65:525-7.

14.

Lee-Wong M, Gadhvi D, Resnick S. Clopidogrel desensitization. Ann Allergy Asthma Immunol 2006;96:756-7.

15.

Walker NE, Fasano MB, Horwitz PA. Rapid Communication: Desensitization for the Management of Clopidogrel Hypersensitivity: Initial Clinical Experience. J Invasive Cardiol 2006;18:341-44.

Title: Rapid oral desensitisation procedure in clopidogrel hypersensitivity
Authors: B. Oppedijk
D. A. M. Odekerken
J. J. van der Wildt
C. F. Melissant
Publication date: 01-01-2008
Publisher: Bohn Stafleu van Loghum
Published in: Netherlands Heart Journal / Issue 1/2008
Print ISSN: 1568-5888
Electronic ISSN: 1876-6250
DOI: https://doi.org/10.1007/BF03086112

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Rapid oral desensitisation procedure in clopidogrel hypersensitivity

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2008

The first 20 years of bradypacing in the Netherlands - with special reference to organisational structures

8 October 1958, D Day for the implantable pacemaker

Thrombus in a normal left ventricle

Epigenetic histone acetylation modifiers in vascular remodelling – new targets for therapy in cardiovascular disease

Mechanisms involved in symptomatic myocardial bridging

Ambulance diagnosis of ST elevation myocardial infarction eligible for primary PCI